You are asking the right question, how much do they need?
I did some math a few weeks back (can't remember what thread it was on), but essentially it gave a range of cash that was needed. To be honest, I do not know, we can only try and work backwards from what they have reported.
I suggest we should be thinking they need to jab / test between 300 to 650 people at a cost of circa US$50k each. I would err on the high side, given I think the FDA will ask for all the same monitoring from phase 1
I will dig out those previous thoughts.
You are asking the right question, how much do they need?I did...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $83.95M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.3¢ | 24.0¢ | $40.77K | 169.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 134085 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 65047 | 7 |
View Market Depth
| Last trade - 15.36pm 12/06/2024 (20 minute delay) ? |
|
|||||
|
Last
24.0¢ |
Change
0.000 ( 1.15 %) |
||||
| Open | High | Low | Volume | ||
| 24.3¢ | 24.3¢ | 24.0¢ | 18082 | ||
| Last updated 15.57pm 12/06/2024 ? | |||||
| PAR (ASX) Chart |